CIK: 1450324 - Address: 2117 Southwest Highway 484, Ocala,, FL 34473
37 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11152-31-20-32-52-17
P%wins875357001135

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/18/24 15:01
3/15/24
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP250.330007612716D
11/27/23 12:56
11/27/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP150.44300346641D
9/29/23 15:29
9/29/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP100.44100234607D
8/25/23 14:26
8/25/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP60.6690081584D
8/24/23 13:52
8/24/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP100.66700153576D
7/17/23 19:20
7/17/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP100.59000173561D
1/4/23 07:30
1/3/23
AIMAim Immunotech Inc.FLHealthBioPrdBiological Products, (No DiagEquels Thomas KFLDOCEO,PP500.3100016142544D
7/16/21 12:07
7/16/21
AIMAim Immunotech Inc.DEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP301.920167225D
2/24/21 12:03
2/24/21
AIMAim Immunotech Inc.DEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP252.260116210D
12/17/20 12:22
12/17/20
AIMAim Immunotech Inc.DEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEOP251.720158199D
9/3/20 10:53
9/3/20
AIMAim Immunotech Inc.DEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP252.030127184D
8/21/20 08:08
8/21/20
AIMAim Immunotech Inc.DEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEOP252.330117172D
6/27/19 15:32
6/27/19
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP124.3703463D
6/25/19 12:17
6/21/19
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP.a1184.030299560D
6/21/19 11:11
6/21/19
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP1184.0302921,394D
3/19/19 16:01
3/19/19
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP20.17550132812D
12/3/18 11:32
11/30/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP40.19230203798D
10/29/18 09:14
10/26/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP10.2030040776D
10/25/18 09:22
10/25/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP200.2000010015772D
7/27/18 09:31
7/27/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP100.29000345672D
7/23/18 10:49
7/23/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOExec. ViP350.3100011322638D
4/30/18 06:22
4/27/18
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP100.32000326525D
4/27/17 09:27
4/27/17
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP500.690007217493D-75-62-31033301919-3-1
4/11/17 09:54
4/11/17
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP1000.5000020091420D-81-66-54-2910-4006819
12/23/16 12:31
12/22/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP500.730006845220D-76-28-52-44-23-14-18-71000-20
11/1/16 13:27
11/1/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP101.000107152D-72-37-42-42-26-16-8-9-6-9-16-35-31
7/8/16 17:10
7/8/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP60.118404831,704D-60-3750-809000058-17-47
7/1/16 16:17
6/29/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,PP.m200.11940171121,656D-63-405009000008-13-52
3/21/16 09:33
3/18/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,P,ExP40.132203021,485D-68-43-28300-7-19-1915-88-15-5-65
3/14/16 11:16
3/11/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,P,ExP.a60.157804031,455D-62-30-64578-6070-19-19-25-28-72
3/14/16 10:47
3/10/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,P,ExP.a50.163003021,415D-62-30-64578-6070-19-19-25-28-72
3/14/16 08:17
3/11/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,P,ExP60.157804010D-62-30-64578-6070-19-19-25-28-72
3/10/16 15:57
3/10/16
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCEO,P,ExP50.1630030New30D-62-33-645782314700-19-19-29-71
8/14/15 10:59
8/13/15
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCFO,P,SeP.m140.180007961,385D-25-36-25-28-10-50-5000-22-330
4/28/15 10:00
4/27/15
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCFO,ViceP240.2443010081,305D0-32-230050-89130-13-39-35
4/21/15 10:00
4/20/15
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCFO,ViceP240.2391010091,205D9-25-250-44940-4-4-17-38-42
4/15/15 12:23
4/15/15
HEBHemispherx Biopharma IncDEHealthBioPrdBiological Products, (No DiagEquels Thomas K.FLDOCFO,ViceP230.22540100101,105D-4-39-35-8-12-8-405918-9-27-36

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact